Illumina, Inc.
LSE: 0J8Z.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Jacob Thaysen
- Employees
- 8,970
- Headquarters
- San Diego, United States
- IPO year
- 2018
- Market cap
- $21.3B
- Website
- https://www.illumina.com
Loading 0J8Z…
Loading profile data…Frequently asked questions about 0J8Z
What does Illumina, Inc. (0J8Z.L) do?
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
Where does 0J8Z.L trade?
Illumina, Inc. (0J8Z.L) trades on the London Stock Exchange.
What sector is 0J8Z.L in?
Illumina, Inc. (0J8Z.L) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Illumina, Inc.?
Jacob Thaysen is the chief executive officer of Illumina, Inc. (0J8Z.L).
Where is Illumina, Inc. headquartered?
Illumina, Inc. is headquartered in United States.
Does 0J8Z.L pay a dividend?
Yes — Illumina, Inc. (0J8Z.L) paid a trailing twelve-month dividend of USD 3.10 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 0J8Z.L go public?
Illumina, Inc. (0J8Z.L) completed its initial public offering in 2018.